timothy sykes logo

Watchlists-Penny Stock Investment Strategy

Top Biotech Penny Stocks to Watch

Timothy SykesAvatar
Written by Timothy Sykes
Reviewed by Friedrich Odermann Fact-checked by Ed Weinberg
Updated 6/14/2024 29 min read

Biotech penny stocks are low-priced shares in small companies that use biological systems and living organisms to create and develop new products and treatments. These stocks are known for their high volatility and potential for significant returns, driven by factors such as clinical trial results, regulatory approvals, and sector-specific news. But watch out — these sketchy stocks have a propensity to dilute their float to raise cash, tanking share value in the process.

Table of Contents

Top Biotech Penny Stocks to Watch

My biotech stock picks for June 2024 are:

  • NASDAQ: MBOT — Microbot Medical Inc — The FDA Approval Breakout Biotech Stock
  • NASDAQ: BPTH — Bio Path Holdings Inc — The Former Supernova Biotech Stock
  • NASDAQ: GNPX — Genprex Inc — My Weekend Winner Low-Float Biotech Stock
  • NASDAQ: ANNX — Annexon, Inc — The Dilution Survivor Biotech Stock
  • NASDAQ: SOBR — Sobr Safe Inc — The New Deal Catalyst Biotech Stock

Disclaimer: This is a watchlist, not a forecast. There’s no guarantee these stocks will offer a trading opportunity or help you hit your trading targets. Keep them on your watchlist, but only trade when you see YOUR best setup.

When there are no truly great trades, use your time to study.

Here’s some background info on biotech penny stocks:

  • What is the most promising biotech penny stock?

A stock with a lot of volatility like Microbot Medical Inc (NASDAQ: MBOT) is a good bet for the most promising biotech penny stock. Remember, we’re traders, not investors. We’re watching the stocks on this list for short-term moves, not predicting which of these stocks will still be around in 2030.

  • What are the top 3 biotech penny stocks to buy now?

My top 3 biotech penny stocks to buy now (as long as their price action is strong) are Microbot Medical Inc (NASDAQ: MBOT), Bio Path Holdings Inc (NASDAQ: BPTH), and Genprex Inc (NASDAQ: GNPX).

  • Which biotech penny stocks have a “Strong Buy” analyst rating?

Analysts don’t give any biotech penny stocks “strong buy” ratings. These stocks are sketchy and unstable, and should never be investment targets. Always trade with a plan.

5 Biotech Penny Stocks To Watch

My top biotech penny stock picks for June — rated on chart pattern, price action history, and news — include the following:

Stock TickerCompanyPerformance (YTD)
NASDAQ: MBOTMicrobot Medical Inc- 12.78%
NASDAQ: BPTHBio Path Holdings Inc- 71.27%
NASDAQ: GNPXGenprex Inc- 70.51%
NASDAQ: ANNXAnnexon, Inc+ 32.28%
NASDAQ: SOBRSobr Safe Inc- 29.71%

The penny stocks on this list are some of the wildest movers on the market …

Trading any of these stocks should be approached with a clear strategy and an understanding of the risks involved. I don’t trade until I see a setup I like.

Now, let’s get to the top biotech penny stocks to watch this month.

Biotech Penny Stock to Watch #1: Microbot Medical Inc (NASDAQ: MBOT) — The FDA Approval Breakout Biotech Stock

Post image

Get my weekly watchlist, free

Sign up to jump start your trading education!

My first biotech penny stock pick is Microbot Medical Inc (NASDAQ: MBOT).

On Monday, June 3, MBOT spiked 130%* before noon.

During premarket that day, the company announced FDA approval to proceed with its human trial of a robotic surgical system.

An FDA approval is a HUGE bullish catalyst for these low-priced stocks.

These small-cap companies don’t announce bullish news very often. So, when they publish a catalyst like an FDA approval … The resulting stock move can be intense.

Below, you can see the Breaking News notification that came out for MBOT overlaid on a chart. Every candle represents one trading minute:

MBOT chart intraday, 1-minute candles Source: StocksToTrade

>> This is where we find Breaking News alerts for the hottest stocks <<

Traders had all morning to build a position on this runner.

Yours truly snagged a 14% profit. You can see my trade notes below.

With a starting stake of $5,845:

Source: Profit.ly

Interested in these plays? Tune in for the next trading live stream, my students and I will show you our trading process in real time.

Bio Path Holdings Inc (NASDAQ: BPTH) — The Former Supernova Biotech Stock

My second biotech penny stock pick is Bio Path Holdings Inc (NASDAQ: BPTH).

Some of the spikes in our niche turn into full-blown supernovas.

It’s a term I coined years ago to describe the INSANE movements among small-cap stocks in our niche.

And when we find a stock that goes supernova, there’s a higher chance the stock will spike again down the road. Past volatility can lead to future volatility.

BPTH has a healthy history of running. In February 2021, the stock spiked 360%* in less than 24 hours.

In October 2023, the stock spiked 170%* … Again, in less than 24 hours.

In 2024, all it needed was a hot catalyst to push the price up again. And sure enough, on June 3 the stock spiked 120%* after the company announced the presentation of its Phase 2 data for a Leukemia study.

Catalysts relating to cancer tend to cause a lot of market volatility because:

  • Cancer is a well known disease.
  • It’s also a scary disease that currently doesn’t have a simple treatment.

You may have missed the first part of this spike, but the chart shows good consolidation that could hint at another move upward.

Take a look at the price action below, I drew in the support line it’s using at $2.50. Every candle represents one trading minute:

BPTH chart multi-day, 1-minute candles Source: StocksToTrade

The sideways momentum is a hint that the stock could spike toward the highs again.

Plus, StocksToTrade shows that the float is only 1.6 million shares …

When stocks have a low float (below 10 million shares) the price is more susceptible to volatility.

The price spikes higher when demand increases because there’s a low supply.

Genprex Inc (NASDAQ: GNPX) — My Weekend Winner Low-Float Biotech Stock

My third biotech penny stock pick is Genprex Inc (NASDAQ: GNPX).

Every Friday we watch for the same pattern in the stock market.

Fridays are unique because of the weekend. Markets are closed on Saturday and Sunday.

As a result, we usually see a peculiar similarity on Fridays.

  • Short sellers are nervous about a Monday gap up.
    • They buy back shares to exit.
  • Long-biased traders are excited to take advantage of the same Monday gap ups.
    • They buy shares to open positions.

This bullish sentiment causes an identifiable trading pattern in the market …

See the video tutorial below:

I used this exact pattern to play GNPX between May 31 and June 3.

My trade notes are below, with a starting stake of $10,767:

Source: Profit.ly

Now, there’s no telling which stock will spike this Friday.

Use the GNPX price action to study these plays.

Not familiar with the weekend trade pattern? Take a look at the pattern tutorial and compare that price action to GNPX.

The more examples that you see, the faster you’ll learn this process for profits.

Keep an eye on GNPX in June … StocksToTrade shows that the float is only 1.7 million shares. Remember, the low supply hints at a possible upcoming spike!

Annexon, Inc (NASDAQ: ANNX) — The Dilution Survivor Biotech Stock

My fourth biotech penny stock pick is Annexon, Inc (NASDAQ: ANNX).

On June 3 during after hours, the company announced an upcoming conference call scheduled for June 4 to discuss Phase 3 data for its treatment of Guillain-Barré syndrome

All told, between June 3 and 4, the stock spiked 60% due to the conference call.

Then, on June 4 during after hours, the company proposed a public offering of stock.

This is something that’s fairly common for small-cap biotech stocks: They spike the price, then they hold public offerings as a cash grab.

The influx of shares dilutes the total share count and usually causes the stock price to drop.

But ANNX is still holding its gains … Take a look at the chart below. Every candle represents one trading minute:

ANNX chart multi-day, 1-minute candles Source: StocksToTrade

The stock’s persistent strength after a share dilution is a huge sign of bullish momentum.

Wait for the price action to match one of our trading patterns. And use my AI-trading bot to ensure you’re playing the right setup!

This is still a dangerously volatile stock, don’t get stuck on the wrong side of the move.

Sobr Safe Inc (NASDAQ: SOBR) — The New Deal Catalyst Biotech Stock

My fifth biotech penny stock pick is Sobr Safe Inc (NASDAQ: SOBR).

On June 4, SOBR announced a new business agreement with two recovery-service companies, Hired Power and The Firm. The stock spiked 180%* as a direct result.

The recovery companies have previously made purchases from SOBR and are reportedly implementing SOBR breathalyzers for remote-client monitoring.

SOBR also experienced volatility in the final weeks of May, prior to the new-deal spike.

The history of volatility was a good indication of SOBR’s ability to spike again on June 4. But the highs from May’s spike stunted June’s run. Take a look at the chart below, every candle represents one trading minute:

SOBR chart multi-day, 1-minute candles Source: StocksToTrade

Pay attention to the multi-day charts on these stocks! The price action can give us valuable insights about possible entry and exit points.

Considering SOBR’s history of spiking … It’s only a matter of time until the next price surge.


*Past performance does not indicate future results

What Are Biotech Penny Stocks?

© Millionaire Media, LLC

Biotech penny stocks refer to shares of small biotech companies that trade for less than $5 — stocks in pharmaceutical companies with drugs in development. Recent biotech spikers have come from the following areas:

  • Companies working on COVID-19 vaccines and tests
  • Companies working in pandemic relief and control
  • Firms researching cancer medicines and immuno-oncology drugs
  • Companies developing medicines for rare disorders

These companies are usually desperate for cash from investors. They need it to send their products through multiple phases of testing and stages of trials.

That’s their focus in the markets — to keep stock prices high by selling their progress. When their share prices grow enough, they’ll dilute to cash in, leaving bag holders with big losses…

They’re known to be extremely volatile. One minute they’re flying high on positive headlines — the next they’re down due to bad trial results, side effects on patients, FDA approval issues, or stock dilution.

That’s why I ride the hype but never believe it.

Penny stocks are some of the sketchiest stocks in the market. They suck in newbies with their upside, and these newbies start to believe as share value increases…

There are ways to profit off biotech stocks — as long as you know how the niche works. I learned by making my own mistakes.

I started trading in high school. By the time I graduated college, I had grown my small account from $12,415 to roughly $2 million. I also made some world-class blunders. Read all about it in my best-selling no-cost book, “An American Hedge Fund.”

I’ve now made over $7.7 million in profits. So far, I’ve taught 30+ millionaire students how to trade with a small account in my Trading Challenge.

**Apply for the Trading Challenge Today**

Challenge students get access to all my top tips and trading education resources — including my daily watchlists.

To become a self-sufficient trader, you have to learn how to build your own watchlist. So study up and learn the logic behind my stock picks…

Is It a Wise Decision to Invest in Biotech Penny Stocks?

© Millionaire Media, LLC

These stocks are high-risk, high-reward plays in the biotech industry, offering potential for significant gains but also carrying substantial risk. In this article, we’ll delve into the pros and cons of investing in biotech penny stocks, the factors to consider, and why some biotech penny stocks might be better picks than others.

While the focus here is on biotech stocks, you might be wondering if penny stocks can be a long-term investment. The answer is nuanced. While they’re generally considered short-term plays, there are exceptions. Want to know more about how to approach penny stocks for the long haul? Here’s a guide that delves into long-term strategies with penny stocks.

Biotech Stocks Under $5

The allure of hot sector stocks, especially when they’re also penny stocks, is undeniable. These stocks present a unique blend of opportunity and volatility. The biotech industry is booming, with advancements and applications spreading across various sectors, from drug development to gene editing, making biotech stocks a magnet for investors looking for the next big breakthrough. The gains here can be proportionately greater than those from more established stocks, mainly because even minor positive developments or clinical trial results can send their prices soaring.

However, it’s crucial to approach these opportunities with a clear strategy and an understanding of the risks involved. The volatility of penny stocks, combined with the speculative nature of biotech ventures, means that while the potential for rapid gains is significant, the risk of losses is equally high. Conduct thorough research, looking beyond the hype. And never invest in these stocks — only trade them.

Remember, the key to success in trading biotech stocks under $5 is not just about jumping on every opportunity but being selective and strategic. It’s about leveraging the explosive potential of the biotech sector while managing risk meticulously. By focusing on companies with the potential to lead in their niche, traders can capitalize on the disproportionate gains that these penny stocks offer, all while keeping their investment strategy tight and cutting losses quickly.

My best tip is to look beyond biotech penny stocks — healthcare and medical stocks give traders the same upside potential and trade-worthy volatility. Researching these stocks can help you diversify your trading portfolio and give you a better chance to be watching a hot stock when it pops off. Check out my watchlist of Healthcare and Medical Stocks.

What Is the Best Biotech Stock To Buy Right Now?

I can’t tell you the “best” biotech stock to buy right now because the market is always changing. What I can tell you is to look at factors like market cap, liquidity, and EPS (earnings per share). These are crucial indicators that can give you an edge. I’ve been trading for years, and I can tell you that understanding these metrics is a game-changer.

You can get your intel from TipRanks links and Wall Street analysts — but remember, they’re not always right. You’ve got to do your own research. Dive into the company’s pipeline, check out their science, and maybe even look into the careers of the top executives. The more you know, the better your strategy will be.

There’s no need to limit yourself to sketchy biotechs in the US — check out this list of top pharmaceutical stocks in Canada! Vancouver is a hub of biotech activity, and Toronto is where insulin was discovered so you know it isn’t Canada’s first biotech rodeo. For more ideas, visit my article on the Top Pharmaceutical Stocks in Canada.

Why Other Biotech Penny Stocks Were Not Chosen

When it comes to biotech penny stocks, not all are created equal. Some have strong growth potential backed by innovative therapies and treatments for diseases, while others might just be riding the hype. It’s crucial to conduct thorough analysis before diving in. Let’s explore why some biotech penny stocks might not make the cut.

  • Clinical Indications and Approvals: Biotech companies often focus on specific clinical indications. If a company doesn’t have any therapies or treatments that have received approvals or shown promise in clinical trials, it’s a red flag. Regulatory approvals are milestones that can significantly impact a biotech company’s stock price.
  • Financial Health: Revenue and Debt: Another critical factor is the company’s financial health. A biotech company with high debt and low revenue is a risky investment. Always check the balance sheet. Brokers and analysts often provide this information, but it’s best to do your own due diligence. Look at rates of revenue growth and how the company manages its debt.

Get the List of Penny Stocks I’m Watching Delivered to Your Inbox

© Millionaire Media, LLC

Want to know the top stocks I’m watching each week? I’ve got a watchlist for that. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.

Remember: the stocks in my newsletters aren’t automatic buys. You should only listen to your own opinions. Do your own due diligence and research before considering a stock for your trading portfolio.

👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.

How do I find the hottest stocks to trade? I use StocksToTrade every day. It has awesome charts, built-in scanner tools, social media feeds, and a range of other helpful features to help you crunch data and do your research.

Its Breaking News Chat feature is a game-changer — it helped me make over $1 million in trading profits in 2021, when biotech news was behind many of the best spikers I’ve seen in my 20+ years trading. I seriously think every trader should have this tool working for them. It’s one of the best trading platforms out there.

Try a StockToTrade 14-day trial for only $7 … or take a two-week look at the Breaking News Chat for only $17!

Things You Need to Know Before Investing in Biotech Penny Stocks

Thanks to their volatility, biotechs can drain your investments faster than you can enter the ticker name in the order window. Banks and traditional finance institutions often steer clear of these for a reason. But if you’re like me, you see the potential for massive gains. I’ve been teaching trading strategies for years, and one thing I always emphasize is risk management.

Before you even think about diving in, understand the economy you’re playing in. Look at dividends, if any, and how the company is positioned in its region. Check out exchanges where the stock is listed; some are more reputable than others. And for heaven’s sake, don’t put all your eggs in one basket. Diversification is key.

If you’re already committed to doing your homework, why not take it a step further? There are biotech companies out there that are just waiting to be discovered. These hot biotechs could be the next big thing, and your research could lead you right to them.

Interested in finding these hidden gems? Check out this list of former runners. And remember…

Former runners can run again!

How To Trade Biotech Penny Stocks The Right Way

So you’re still with me? Good. Hopefully, the Instagram trading influencers have already clicked off to go blow up their accounts. Trading biotech penny stocks the right way involves a well-thought-out strategy. I’ve been in this game long enough to know that you can’t rely on luck. You need a solid plan, and you need to stick to it.

First off, don’t ignore the news and events surrounding the biotech sector. This industry is heavily influenced by views from the scientific community, FDA approvals, and other significant events. Keep an eye on these, and you’ll be ahead of the game. Also, consider using credit cards wisely to manage your liquidity, but be cautious of the risks involved.

How do you get ahead of the game? That’s all about finding a biotech penny stock before it makes headlines. It’s possible, but it requires a specific approach. Learn my method for finding penny stocks pre-spike here.

Legal Considerations When Trading Biotech Penny Stocks

When trading biotech penny stocks and other small-cap stocks, you need to understand the legal considerations specific to these securities. It’s not that you’re going to make a mistake and get your account locked down — that’s something you’ve got to watch out for in all stocks if you’re under the PDT — but keeping your eye off the ball with sketchy therapeutics companies can cost you money.

The biotech sector is heavily regulated, and this complexity adds layers of risk. Regulators are on the lookout for snake-oil salesmen behind the latest penny stock “innovations” — these are the major ways that biotech stocks are affected:

  • Complex regulatory environment
  • High risk of volatile price movements
  • Increased scrutiny from regulatory bodies
  • Potential for insider trading violations
  • Mandatory disclosure requirements

Compliance With SEC Regulations

The Securities and Exchange Commission (SEC) plays a big role in regulating stocks. This is what your favorite biotech penny stock should be aware of:

  1. Registration of Securities: Companies must register their securities with the SEC.
  2. Disclosure of Information: Detailed financial information must be disclosed.
  3. Reporting Requirements: Regular financial reports must be filed.
  4. Prohibition of Fraudulent Activities: Strict rules against fraud and market manipulation.
  5. Broker-Dealer Requirements: Brokers must comply with specific regulations when handling penny stocks.

Awareness of Penny Stock Rules (SEC Rule 15g-9)

Penny stocks are defined as stocks trading for less than $5 per share and are subject to SEC Rule 15g-9. This rule aims to protect investors from high-risk investments by ensuring that brokers follow specific compliance procedures.

  • Brokers must provide a disclosure document outlining the risks of penny stocks.
  • Investors must sign and return a copy of this document before any trades are executed.
  • Brokers must determine that penny stock transactions are suitable for the investor.
  • Monthly account statements must be provided to the investor.

Understanding Insider Trading Laws

Insider trading involves trading a public company’s stock based on non-public, material information about the company. This practice is illegal and carries severe consequences, especially in the biotech sector, where insider information can significantly impact stock prices.

This is one of the big “tells” behind sketchy biotech stocks that you absolutely should not be holding overnight. Watch out for the following:

  • Fines and penalties imposed by the SEC
  • Criminal charges leading to imprisonment
  • Permanent bans from trading activities
  • Significant reputational damage

Disclosure Requirements

Several types of disclosures are legally required when trading biotech penny stocks to maintain transparency and protect investors.

  1. Material Event Disclosure: Significant events like mergers or product approvals.
  2. Financial Statement Disclosure: Detailed and accurate financial statements.
  3. Management Discussion and Analysis: Insight into financial health and management strategies.
  4. Risk Factor Disclosure: Potential risks involved in the investment.
  5. Insider Holdings Disclosure: Information about shares held by insiders.

These disclosures help maintain market integrity and protect investors by ensuring they have access to all material information before making investment decisions.

Risks of Market Manipulation

Market manipulation is a significant risk in the penny stock market, especially in the biotech sector. As always, do your due diligence, be skeptical of overly positive news, and monitor trading volumes for unusual spikes.

And watch out for these tricks!

  • Promoter pumps: Artificially inflating stock prices before selling off.
  • Spoofing: Placing and then canceling large orders to manipulate prices.
  • Wash trading: Simultaneously buying and selling shares to create fake volume.

Impact of Regulatory Approvals and Rejections

The prices of biotech penny stocks are highly sensitive to FDA regulatory approvals and rejections. A positive FDA decision can send stock prices soaring, while a rejection can lead to significant losses.

Biotech Penny Stocks: The Bottom Line

© Millionaire Media, LLC

Penny stock trading is a great way to build your account as a new trader. Biotech penny stocks are some of the hottest movers on the market — but this volatility can cut both ways..

Key Considerations:

  • A lot of penny stocks are shady. Risk in biotech penny stocks can be heightened due to limited company information and unsavory promotion. When the price gets up high enough, nine times out of 10 these companies will do new share offerings, tanking share price.
  • There’s a possibility for big gains. I trade biotech penny stocks because you can trade conservatively and still rack up gains. These stocks can go supernova at any time. Aim for “the meat of the move.”
  • These companies are often young. Some biotech penny stocks are newer companies, and can dramatically shift their market trajectory and valuation.

Trading isn’t rocket science. It’s a skill you build and work on like any other. Trading has changed my life, and I think this way of life should be open to more people…

I’ve built my Trading Challenge to pass on the things I had to learn for myself. It’s the kind of community that I wish I had when I was starting out.

We don’t accept everyone. If you’re up for the challenge — I want to hear from you.

Apply to the Trading Challenge here.

Trading is a battlefield. The more knowledge you have, the better prepared you’ll be.

Have you traded penny biotech stocks? Write “I always trade with a plan” in the comments!

Biotech Penny Stock FAQs

What Biotech Sectors Should I Focus On?

When it comes to biotechnology, you’ve got a smorgasbord of options. Genomics and cell therapies are hot right now. Don’t overlook stem cells; they’re a cornerstone in healthcare solutions. Diversifying across these sectors can be a smart move.

What Investment Vehicles Are Suitable for Biotech Penny Stocks?

You’ll hear me say it a million times: diversification is key. Consider ETFs that focus on biotech. If you’re into individual stocks, keep an eye on ipo listings and blue-chip companies that have a biotech arm. Setting a price target can help, and don’t forget, you can also use an ira to hold these assets.

How Do Market Dynamics Affect Biotech Penny Stocks?

Market dynamics are the bread and butter of trading. Keep an eye on buyers and their positions, especially in penny shares and penny stocks. Pharmaceutical stock can be volatile, so understanding the market sentiment is crucial.

How Can I Analyze Biotech Penny Stocks?

We’re here for the long haul, so get familiar with the tools of the trade. A stock biotech chart is invaluable for technical analysis. Keep a stocks list for quick reference, and don’t forget to compare pharma stocks to get a broader view.

What Additional Factors Should I Consider?

You don’t have to mirror my techniques, but you should watch the stock charts of former runners like Nymox Pharmaceutical Corp (OTCPK: NYMXF), Ardelyx, Inc. (NASDAQ: ARDX), and Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL). Articles and technology updates can provide valuable insights. Sales figures, types of services offered, and partnerships can also be indicators of a stock’s potential. Exercise caution and listen to the response from scientists in the field to make an informed decision.

How much has this post helped you?

Leave a reply

Author card Timothy Sykes picture

Timothy Sykes

Tim Sykes is a penny stock trader and teacher who became a self-made millionaire by the age of 22 by trading $12,415 of bar mitzvah money. After becoming disenchanted with the hedge fund world, he established the Tim Sykes Trading Challenge to teach aspiring traders how to follow his trading strategies. He’s been featured in a variety of media outlets including CNN, Larry King, Steve Harvey, Forbes, Men’s Journal, and more. He’s also an active philanthropist and environmental activist, a co-founder of Karmagawa, and has donated millions of dollars to charity. Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”